Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wiewrodt

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Pneumologie (Stuttgart, Germany)|April 16, 1998
[Effectiveness and tolerance of a combination of fluticasone and salmeterol in patients with obstructive airway diseases. DUO Study Group]R Wiewrodt, N Dauletbaev, R Buhl
Deutsche Medizinische Wochenschrift (1946)|October 1, 2011
[Thoracic oncology]L H Schmidt, M Mohr, R Wiewrodt
Annals of Internal Medicine|April 15, 2000
Gene therapy for lung disease: hype or hope?S M Albelda, R Wiewrodt, J B Zuckerman
Pneumologie (Stuttgart, Germany)|September 6, 2013
[Employing tyrosine kinase inhibitors in the first line treatment of EGFR-positive metastatic NSCLC - state of the art and recent developments]R Wiewrodt, M Serke, C Grohé, et al.
Pneumologie (Stuttgart, Germany)|May 5, 1999
[Gene therapy in cancers of the lung and pleura]R Wiewrodt, M Schuler, C Huber, et al.
Pneumologie (Stuttgart, Germany)|August 10, 2000
[efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases]K M Beeh, R Wiewrodt, A E Salem, et al.
The European Respiratory Journal|December 5, 1997
Short-term effects of regular salmeterol treatment on adult cystic fibrosis patientsJ Bargon, K Viel, N Dauletbaev, et al.
Pneumologie (Stuttgart, Germany)|February 14, 2002
[Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma]K M Beeh, J Beier, O Kornmann, et al.
Pneumologie (Stuttgart, Germany)|September 8, 2016
[Therapy of Metastatic Non-small Cell Lung Cancer]N Reinmuth, A Gröschel, C Schumann, et al.
Pneumologie (Stuttgart, Germany)|December 23, 2017
[Updated Recommendation for Treatment of Metastatic Non-Small Cell Lung Cancer]N Reinmuth, A Gröschel, C Schumann, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Pneumologie (Stuttgart, Germany)|April 16, 1998
[Effectiveness and tolerance of a combination of fluticasone and salmeterol in patients with obstructive airway diseases. DUO Study Group]R Wiewrodt, N Dauletbaev, R Buhl
Deutsche Medizinische Wochenschrift (1946)|October 1, 2011
[Thoracic oncology]L H Schmidt, M Mohr, R Wiewrodt
Annals of Internal Medicine|April 15, 2000
Gene therapy for lung disease: hype or hope?S M Albelda, R Wiewrodt, J B Zuckerman
Pneumologie (Stuttgart, Germany)|September 6, 2013
[Employing tyrosine kinase inhibitors in the first line treatment of EGFR-positive metastatic NSCLC - state of the art and recent developments]R Wiewrodt, M Serke, C Grohé, et al.
Pneumologie (Stuttgart, Germany)|May 5, 1999
[Gene therapy in cancers of the lung and pleura]R Wiewrodt, M Schuler, C Huber, et al.
Pneumologie (Stuttgart, Germany)|August 10, 2000
[efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases]K M Beeh, R Wiewrodt, A E Salem, et al.
The European Respiratory Journal|December 5, 1997
Short-term effects of regular salmeterol treatment on adult cystic fibrosis patientsJ Bargon, K Viel, N Dauletbaev, et al.
Pneumologie (Stuttgart, Germany)|February 14, 2002
[Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma]K M Beeh, J Beier, O Kornmann, et al.
Pneumologie (Stuttgart, Germany)|September 8, 2016
[Therapy of Metastatic Non-small Cell Lung Cancer]N Reinmuth, A Gröschel, C Schumann, et al.
Pneumologie (Stuttgart, Germany)|December 23, 2017
[Updated Recommendation for Treatment of Metastatic Non-Small Cell Lung Cancer]N Reinmuth, A Gröschel, C Schumann, et al.
Pageof 4